Send to:

Choose Destination

SRX883952: Untreated primary human MEPs isolated form bone marrow of normal donor
3 ILLUMINA (Illumina HiSeq 2500) runs: 116.8M spots, 35G bases, 21.3Gb downloads

Design: MEPs were starved for 1.5h in RPMI with 1% BSA followed by incubation in RPMI with 10% FCS for 2 hours. RNA was isolated with Trizol (Life Technologies) as per the manufacturer’s recommendations and was further facilitated by using linear polyacrylamide (Sigma) as a carrier during the procedure. We treated the total RNA samples with RQ1 RNase free DNase (Promega) to remove minute quantities of genomic DNA if present. DNase treated samples were cleaned up using RNAeasy minelute columns (QIAGEN). 1-10 ng of total RNA was used as input for cDNA preparation and amplification using Ovation RNA-Seq System V2 (NuGEN). Amplified cDNA was sheared using Covaris S2 (Covaris) using the following settings: duty cycle 10%, intensity 5, cycle/burst 100, total time 5 min. The sheared cDNA was cleaned up using Agencourt Ampure XP (Beckman Coulter). 500 ng of sheared cDNA were used as input for library preparation using NEBNext Ultra DNA Library Prep Kit for Illumina (New England BioLabs) as per manufacturer’s recommendations.
Submitted by: Stanford University School of Medicine
Study: Homo sapiens Raw sequence reads
show Abstracthide Abstract
Effect of various synthetic ligands called diabodies on primary human megakaryocyte-erythrocyte progenitors (MEPs) isolated from bone marrow of a normal donor. The diabodies used in our studies act as either agonists or antagonists for erythropoietin receptor (EPOR) expressed on the surface of MEPs.
SAMN03353434 • SRS850966 • All experiments • All runs
Organism: Homo sapiens
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Selection: cDNA
Layout: PAIRED
Spot descriptor:
forward151  reverse

Runs: 3 runs, 116.8M spots, 35G bases, 21.3Gb
Run# of Spots# of BasesSizePublished


Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center